New UK lipid guidance recommends Lp(a) measurement to be included in enhanced lipid profiling for patients with a personal or family history of premature atherosclerotic cardiovascular disease (ASCVD), first-degree relatives with raised serum Lp(a), familial hypercholesterolemia (FH) or other genetic dyslipidaemias, calcific aortic valve stenosis, or a moderate (10-15%) 10-year risk of a cardiovascular event.
